Conduction system pacing vs biventricular resynchronization therapy in systolic dysfunction and wide QRS: mortality, heart failure hospitalization or cardiac transplant (CONSYST-CRT II trial).
Superiority trial that aims to study the composite endpoint consisting of all-cause mortality, cardiac transplant or heart failure hospitalization at 12-month follow-up.
Patient must indicate acceptance to participate in the study by signing an informed consent document.
Patient must be ≥ 18 years of age.
Left bundle branch block, QRS ≥130 and LVEF <=35%. No indication of stimulation for AV block.
Non-left bundle branch block, QRS ≥150 and LVEF <=35%.
Myocardial infarction, unstable angina or cardiac revascularization during the previous 3 months.
Pregnancy.
Participating currently in a clinical investigation that includes an active treatment.
Hospital Clinic of Barcelona
Lead sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Collaborator